Product Images Steglatro

This text appears to be a list of medication names and their corresponding single doses. The last paragraph mentions some sort of calculation involving the medication doses, but it is not clear what the purpose or meaning of this calculation is. The text may be related to a medical study or clinical trial.*

This appears to be a table showing different medications with their respective doses and geometric mean ratios with concomitant medication. There is also a mention of a single dose of 15 mg of a medication called ertugliflozin. No other information is available.*

This appears to be a chart/table showing the mean change from baseline in HbA1c (%) for different treatments (Placebo, Ertuglifiozin 5mg and 15mg) over a certain period of time. The top part of the chart seems to list the time points at which the HbA1c levels were measured. The lower portion of the chart shows the mean changes in HbA1c levels for each treatment group at the end of the study period.*

Steglatro tablets are available in a bottle containing 30 film-coated tablets. Each tablet contains erugliflozin, which is used to manage high blood sugar level among adults with type 2 diabetes. The tablets should be stored at a temperature range between 20°C-25°C (68°F-77°F). The accompanying medication guide must be given to each patient. The text also includes product information such as the NDC and lot number.*

Steglatro is a medication for diabetes, with each tablet containing 15mg of ertugliflozin. The tablets are encoded with a serialization barcode for tracking and come with a medication guide. This specific package contains 30 tablets, and its NDC code is 0006-5364-03.*